These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics. Ocal O; Pashkov V; Kollipara RK; Zolghadri Y; Cruz VH; Hale MA; Heath BR; Artyukhin AB; Christie AL; Tsoulfas P; Lorens JB; Swift GH; Brekken RA; Wilkie TM Dis Model Mech; 2015 Oct; 8(10):1201-11. PubMed ID: 26438693 [TBL] [Abstract][Full Text] [Related]
3. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677 [TBL] [Abstract][Full Text] [Related]
4. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas. Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042 [TBL] [Abstract][Full Text] [Related]
5. miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis. Ge W; Goga A; He Y; Silva PN; Hirt CK; Herrmanns K; Guccini I; Godbersen S; Schwank G; Stoffel M Gastroenterology; 2022 Jan; 162(1):269-284. PubMed ID: 34547282 [TBL] [Abstract][Full Text] [Related]
6. Resolution of Acinar Dedifferentiation Regulates Tissue Remodeling in Pancreatic Injury and Cancer Initiation. Baldan J; Camacho-Roda J; Ballester M; Høj K; Kurilla A; Maurer HC; Arcila-Barrera S; Lin X; Pan Z; Castro JL; Mayorca-Guiliani AE; Rift CV; Hasselby J; Bouwens L; Lefebvre V; David CJ; Parnas O; DelGiorno KE; Erler JT; Rooman I; Arnes L Gastroenterology; 2024 Sep; 167(4):718-732.e18. PubMed ID: 38729450 [TBL] [Abstract][Full Text] [Related]
7. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet. Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001 [TBL] [Abstract][Full Text] [Related]
9. Identification and manipulation of biliary metaplasia in pancreatic tumors. Delgiorno KE; Hall JC; Takeuchi KK; Pan FC; Halbrook CJ; Washington MK; Olive KP; Spence JR; Sipos B; Wright CV; Wells JM; Crawford HC Gastroenterology; 2014 Jan; 146(1):233-44.e5. PubMed ID: 23999170 [TBL] [Abstract][Full Text] [Related]
10. PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice. Wu CY; Carpenter ES; Takeuchi KK; Halbrook CJ; Peverley LV; Bien H; Hall JC; DelGiorno KE; Pal D; Song Y; Shi C; Lin RZ; Crawford HC Gastroenterology; 2014 Dec; 147(6):1405-16.e7. PubMed ID: 25311989 [TBL] [Abstract][Full Text] [Related]
11. Numb regulates acinar cell dedifferentiation and survival during pancreatic damage and acinar-to-ductal metaplasia. Greer RL; Staley BK; Liou A; Hebrok M Gastroenterology; 2013 Nov; 145(5):1088-1097.e8. PubMed ID: 23891977 [TBL] [Abstract][Full Text] [Related]
12. ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis. Wang L; Yang H; Zamperone A; Diolaiti D; Palmbos PL; Abel EV; Purohit V; Dolgalev I; Rhim AD; Ljungman M; Hadju CH; Halbrook CJ; Bar-Sagi D; di Magliano MP; Crawford HC; Simeone DM Genes Dev; 2019 Jun; 33(11-12):641-655. PubMed ID: 31048544 [TBL] [Abstract][Full Text] [Related]
13. ANGPTL4 accelerates KRAS Yan HH; Jung KH; Lee JE; Son MK; Fang Z; Park JH; Kim SJ; Kim JY; Lim JH; Hong SS Cancer Lett; 2021 Oct; 519():185-198. PubMed ID: 34311032 [TBL] [Abstract][Full Text] [Related]
14. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice. He P; Yang JW; Yang VW; Bialkowska AB Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441 [TBL] [Abstract][Full Text] [Related]
15. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Seifert L; Werba G; Tiwari S; Giao Ly NN; Alothman S; Alqunaibit D; Avanzi A; Barilla R; Daley D; Greco SH; Torres-Hernandez A; Pergamo M; Ochi A; Zambirinis CP; Pansari M; Rendon M; Tippens D; Hundeyin M; Mani VR; Hajdu C; Engle D; Miller G Nature; 2016 Apr; 532(7598):245-9. PubMed ID: 27049944 [TBL] [Abstract][Full Text] [Related]
16. Acute pancreatitis accelerates initiation and progression to pancreatic cancer in mice expressing oncogenic Kras in the nestin cell lineage. Carrière C; Young AL; Gunn JR; Longnecker DS; Korc M PLoS One; 2011; 6(11):e27725. PubMed ID: 22140463 [TBL] [Abstract][Full Text] [Related]
17. Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma. Lee AYL; Dubois CL; Sarai K; Zarei S; Schaeffer DF; Sander M; Kopp JL Gut; 2019 Mar; 68(3):487-498. PubMed ID: 29363536 [TBL] [Abstract][Full Text] [Related]
18. mTORC1 and mTORC2 Converge on the Arp2/3 Complex to Promote Kras Zhao Y; Schoeps B; Yao D; Zhang Z; Schuck K; Tissen V; Jäger C; Schlitter AM; van der Kammen R; Ludwig C; D'Haese JG; Raulefs S; Maeritz N; Shen S; Zou X; Krüger A; Kleeff J; Michalski CW; Friess H; Innocenti M; Kong B Gastroenterology; 2021 Apr; 160(5):1755-1770.e17. PubMed ID: 33388318 [TBL] [Abstract][Full Text] [Related]
19. Dicer regulates differentiation and viability during mouse pancreatic cancer initiation. Morris JP; Greer R; Russ HA; von Figura G; Kim GE; Busch A; Lee J; Hertel KJ; Kim S; McManus M; Hebrok M PLoS One; 2014; 9(5):e95486. PubMed ID: 24788257 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma. Kantheti HS; Hale MA; Pal Choudhuri S; Huang H; Wang XD; Zolghadri Y; Innamorati G; Manikonda SPR; Reddy N; Reddy S; Kollipara RK; Lumani V; Girard L; Bezrukov Y; Demenkov P; MacDonald RJ; Brekken RA; Yu Y; Wilkie TM Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]